Ken Fisher Biocryst Pharmaceuticals Inc Transaction History
Fisher Asset Management, LLC
- $213 Billion
- Q1 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 2,884,619 shares of BCRX stock, worth $18.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,884,619
Previous 2,884,569
-0.0%
Holding current value
$18.6 Million
Previous $17.3 Million
15.19%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding BCRX
# of Institutions
258Shares Held
182MCall Options Held
839KPut Options Held
816K-
Black Rock Inc. New York, NY18.4MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.7MShares$114 Million0.0% of portfolio
-
State Street Corp Boston, MA17.5MShares$113 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY13.1MShares$84.3 Million0.8% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$65.4 Million0.65% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.2B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...